Literature DB >> 18617560

Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.

R Scott Rector1, John P Thyfault, Matthew J Laye, R Tyler Morris, Sarah J Borengasser, Grace M Uptergrove, Manu V Chakravarthy, Frank W Booth, Jamal A Ibdah.   

Abstract

The purpose of this study was to delineate potential mechanisms initiating the onset of hepatic steatosis following the cessation of daily physical activity. Four-week-old, hyperphagic/obese Otsuka Long-Evans Tokushima Fatty rats were given access to voluntary running wheels for 16 weeks to prevent the development of hepatic steatosis. The animals were then suddenly transitioned to a sedentary condition as wheels were locked (wheel lock; WL) for 5 h (WL5), 53 h (WL53) or 173 h (WL173). Importantly after the cessation of daily exercise (5-173 h), no changes occurred in body weight, fat pad mass (omental and retroperitoneal), food intake, serum insulin, hepatic triglycerides or in the exercise-suppressed hepatic stearoyl-CoA desaturase-1 and peroxisome proliferator-activated receptor-gamma protein content. However, complete hepatic fatty acid oxidation and mitochondrial enzyme activities were highest at WL5 and WL53 and dropped significantly to SED levels by WL173. In addition, cessation of daily exercise quickly increased the hepatic protein contents of fatty acid synthase and acetyl-coenzyme A carboxylase (ACC), reduced ACC phosphorylation status, and dramatically increased hepatic malonyl-CoA concentration. This study is the first to show that the sudden cessation of daily exercise in a hyperphagic/obese model activates a subgroup of precursors and processes known to initiate hepatic steatosis, including decreased hepatic mitochondrial oxidative capacity, increased hepatic expression of de novo lipogenesis proteins, and increased hepatic malonyl CoA levels; each probably increasing the susceptibility to non-alcoholic fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617560      PMCID: PMC2652173          DOI: 10.1113/jphysiol.2008.156745

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

Authors:  T Ueno; H Sugawara; K Sujaku; O Hashimoto; R Tsuji; S Tamaki; T Torimura; S Inuzuka; M Sata; K Tanikawa
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

2.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

3.  Entry of [(1,2-13C2)acetyl]-L-carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious, freely moving rats.

Authors:  T Aureli; C Puccetti; M E Di Cocco; A Arduini; R Ricciolini; M Scalibastri; C Manetti; F Conti
Journal:  Eur J Biochem       Date:  1999-07

4.  AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.

Authors:  D M Muoio; K Seefeld; L A Witters; R A Coleman
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

5.  Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.

Authors:  E S Pizer; J Thupari; W F Han; M L Pinn; F J Chrest; G L Frehywot; C A Townsend; F P Kuhajda
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

6.  Effect of AICAR treatment on glycogen metabolism in skeletal muscle.

Authors:  William G Aschenbach; Michael F Hirshman; Nobuharu Fujii; Kei Sakamoto; Kirsten F Howlett; Laurie J Goodyear
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

7.  Running wheel activity prevents hyperphagia and obesity in Otsuka long-evans Tokushima Fatty rats: role of hypothalamic signaling.

Authors:  Sheng Bi; Karen A Scott; Jayson Hyun; Ellen E Ladenheim; Timothy H Moran
Journal:  Endocrinology       Date:  2004-12-29       Impact factor: 4.736

8.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

9.  Is exercise training effective in preventing diabetes mellitus in the Otsuka-Long-Evans-Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus?

Authors:  K Shima; K Shi; T Sano; T Iwami; A Mizuno; Y Noma
Journal:  Metabolism       Date:  1993-08       Impact factor: 8.694

10.  Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain.

Authors:  K Kawano; T Hirashima; S Mori; Y Saitoh; M Kurosumi; T Natori
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

View more
  48 in total

1.  Exercise: not just a medicine for muscle?

Authors:  John P Thyfault; R Scott Rector
Journal:  J Physiol       Date:  2010-08-01       Impact factor: 5.182

2.  The muscle-liver axis: does aerobic fitness induce intrahepatic protection against non-alcoholic fatty liver disease?

Authors:  J A Romijn; H Pijl
Journal:  J Physiol       Date:  2009-04-15       Impact factor: 5.182

3.  Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue.

Authors:  Matthew J Laye; R Scott Rector; Sarah J Borengasser; Scott P Naples; Grace M Uptergrove; Jamal A Ibdah; Frank W Booth; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2008-10-30

4.  Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.

Authors:  R Scott Rector; John P Thyfault; Grace M Uptergrove; E Matthew Morris; Scott P Naples; Sarah J Borengasser; Catherine R Mikus; Matthew J Laye; M Harold Laughlin; Frank W Booth; Jamal A Ibdah
Journal:  J Hepatol       Date:  2010-03-04       Impact factor: 25.083

5.  Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Med Sci Sports Exerc       Date:  2015-03       Impact factor: 5.411

Review 6.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

7.  Postnatal exposure to voluntary exercise but not the antioxidant catechin protects the vasculature after a switch to an atherogenic environment in middle-age mice.

Authors:  Francois Leblond; Albert Nguyen; Virginie Bolduc; Jean Lambert; Carol Yu; Natacha Duquette; Eric Thorin
Journal:  Pflugers Arch       Date:  2013-01-06       Impact factor: 3.657

8.  Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; Monica L Kearney; Jacqueline M Crissey; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

9.  Exercise training decreases hepatic SCD-1 gene expression and protein content in rats.

Authors:  Siham Yasari; Denis Prud'homme; Donghao Wang; Marek Jankowski; Emile Levy; Jolanta Gutkowska; Jean-Marc Lavoie
Journal:  Mol Cell Biochem       Date:  2009-09-24       Impact factor: 3.396

10.  A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; Grace M Meers; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-21       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.